Calithera Biosciences Balance Sheet Health
Financial Health criteria checks 4/6
Calithera Biosciences has a total shareholder equity of $20.4M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $28.7M and $8.3M respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
| Interest coverage ratio | n/a |
| Cash | US$25.45m |
| Equity | US$20.39m |
| Total liabilities | US$8.28m |
| Total assets | US$28.68m |
Recent financial health updates
Is Calithera Biosciences (NASDAQ:CALA) In A Good Position To Invest In Growth?
Aug 17
We Think Calithera Biosciences (NASDAQ:CALA) Needs To Drive Business Growth Carefully
Dec 17We Think Calithera Biosciences (NASDAQ:CALA) Needs To Drive Business Growth Carefully
Aug 27Recent updates
Calithera gains 16% as FDA awards Fast Track status for lung cancer candidate
Oct 03Calithera rises 8% after HC Wainwright upgrades rating to buy
Aug 29Is Calithera Biosciences (NASDAQ:CALA) In A Good Position To Invest In Growth?
Aug 17We Think Calithera Biosciences (NASDAQ:CALA) Needs To Drive Business Growth Carefully
Dec 17We Think Calithera Biosciences (NASDAQ:CALA) Needs To Drive Business Growth Carefully
Aug 27The Upcoming Calithera Cystic Fibrosis Data Could Be Significant
Aug 03Calithera Biosciences Investor Presentation - Slideshow
May 08Is Calithera Biosciences (NASDAQ:CALA) In A Good Position To Deliver On Growth Plans?
May 02What Kind Of Investors Own Most Of Calithera Biosciences, Inc. (NASDAQ:CALA)?
Mar 10Calithera Biosciences, Inc. (NASDAQ:CALA) Shares Could Be 46% Below Their Intrinsic Value Estimate
Jan 17Calithera sinks as telaglenastat fails in kidney cancer study; lowers headcount
Jan 04Companies Like Calithera Biosciences (NASDAQ:CALA) Are In A Position To Invest In Growth
Dec 13Calithera Biosciences Poised For Long-Term Success
Nov 25Calithera Biosciences (CALA) Investor Presentation - Slideshow
Nov 06Financial Position Analysis
Short Term Liabilities: CALA's short term assets ($26.6M) exceed its short term liabilities ($7.4M).
Long Term Liabilities: CALA's short term assets ($26.6M) exceed its long term liabilities ($894.0K).
Debt to Equity History and Analysis
Debt Level: CALA is debt free.
Reducing Debt: CALA has not had any debt for past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: Insufficient data to determine if CALA has enough cash runway based on its current free cash flow.
Forecast Cash Runway: Insufficient data to determine if CALA has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.